Track topics on Twitter Track topics that are important to you
Anil Singhal has been appointed president and CEO of Adicet Bio. He succeeds Donald Santel, who had been interim CEO since founder and former CEO Aya Jakobovits retired last year. Santel will continue...
OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. Our most advanced program, ONCR-201 is an anti-EMP2 fu...
We have published hundreds of OncoResponse news stories on BioPortfolio along with dozens of OncoResponse Clinical Trials and PubMed Articles about OncoResponse for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OncoResponse Companies in our database. You can also find out about relevant OncoResponse Drugs and Medications on this site too.